OOIR: Observatory of International Research

Papers

(The median citation count of Cancer Science is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)

Article	Citations
Issue Information	119
Issue Information	100
Issue Information	91
Issue Information	89
Issue Information	88
Identification of sequence polymorphism in the D‐loop region of mitochondrial DNA as a risk factor for breast cancer	76
Correction to “ELF3‐AS1 contributes to gastric cancer progression by binding to hnRNPK and induces thrombocytosis in peripheral blood”	75
Correction to “Expression of concern: Hydroxychavicol, a Piper betle leaf component, induces apoptosis of CML cells through mitochondrial reactive oxygen species‐dependent JNK	66
Expression of Concern: Hydroxychavicol, a Piper betle leaf component, induces apoptosis of CML cells through mitochondrial reactive oxygen species‐dependent JNK and endothelial nitric oxide syn	64
Retraction	63
LINC01605 promotes aerobic glycolysis through lactate dehydrogenase A in triple‐negative breast cancer	61
Novel CHI3L1‐Associated Angiogenic Phenotypes Define Glioma Microenvironments: Insights From Multi‐Omics Integration	50
Limb expression 1‐like protein promotes epithelial–mesenchymal transition and epidermal growth factor receptor‐tyrosine kinase inhibitor resistance via nucleolin‐mediated ribosomal RNA synt	49
Boron neutron capture therapy delays the decline in neurological function in a mouse model of metastatic spinal tumors	48
PBK Expression Promotes the Aggressive Phenotypes of Mesothelioma	48
GGCT Inhibits Ferroptosis in PTC Cells by Upregulating p53 Through RPS15A	47
Genome‐wide loss‐of‐function genetic screen identifies INSIG2 as the vulnerability of hepatitis B virus‐integrated hepatoma cells	47
Prognostic and Predictive Value of Machine Learning‐Based Biomarker and Pathomics Signatures in Patients With Prostate Cancer	47
Thrombospondin‐1 induced programmed death‐ligand 1‐mediated immunosuppression by activating the STAT3 pathway in osteosarcoma	46
A Contrast‐Enhanced Ultrasound Cine‐Based Deep Learning Model for Predicting the Response of Advanced Hepatocellular Carcinoma to Hepatic Arterial Infusion Chemotherapy Combined With Systemic Therapie	45
Mitochondrial dynamics as a pathobiological mediator of clonal myeloid disorders	45
Tumor Endothelial Cells Induce M2 Macrophage Polarization via IL ‐4, Enhancing Tumor Growth in Hep	43
Head and Neck Cancer Immunotherapy: Overcoming Limitations and Enhancing Efficacy	41
Involvement of protumor macrophages in breast cancer progression and characterization of macrophage phenotypes	40
LHPP‐P38 MAPK/ERK‐ETS1 Axis Negative Feedback Signaling Restrains Progression in Breast Cancer	40

Comparison of ¹¹C‐Acetate and ¹⁸F‐FDG PET/CT for Immune Infiltration and Prognosis in Hepatocellular Carcinoma	39
	39
Epidemiology of skin cancer based on Japan's National Cancer Registry 2016–2017	37
Histological diagnostic discrepancy and its clinical impact in bone and soft tissue tumors referred to a sarcoma center	37
Novel and efficient method for culturing patient‐derived gastric cancer stem cells	37
Induction of immunogenic cell death in murine colon cancer cells by ferrocene‐containing redox phospholipid polymers	37
Formin‐like 2 promotes angiogenesis and metastasis of colorectal cancer by regulating the EGFL6/CKAP4/ERK axis	36
The emerging multifaceted role of PINK1 in cancer biology	36
EGFR inhibition in EGFR‐mutant lung cancer cells perturbs innate immune signaling pathways in the tumor microenvironment	36
Tumor exosomal RNPEP promotes lung metastasis of liver cancer via inducing cancer‐associated fibroblast activation	36
Feedforward loop between IMP1 and YAP/TAZ promotes tumorigenesis and malignant progression in glioblastoma	36
Susceptibility of Brca1^(L63X/+) rat to ovarian reserve dissipation by chemotherapeutic agents to breast cancer	36
Methyltransferase‐like 3 promotes cervical cancer metastasis by enhancing cathepsin L mRNA stability in an N6‐methyladenosine‐dependent manner	35
Trends in incidence and overdiagnosis of thyroid cancer in China, Japan, and South Korea	35
TIFA promotes colorectal cancer cell proliferation in an RSK‐ and PRAS40‐dependent manner	35
Real‐World Data Analysis of Genomic Alterations Detected by a Dual DNA–RNA Comprehensive Genomic Profiling Test	35
Rac1 promotes the reprogramming of glucose metabolism and the growth of colon cancer cells through upregulating SOX9	34
PHAX enhanced LIN28B‐mediated PBX3 mRNA stability to promote esophageal cancer development	34
PLOD2 promotes colorectal cancer progression by stabilizing USP15 to activate the AKT/mTOR signaling pathway	34
TGF‐β signaling promotes desmoid tumor formation via CSRP2 upregulation	34
A Multicenter Phase II Trial of Nimustine Hydrochloride Administered via Convection‐Enhanced Delivery in Children With DIPG	34
Heterogeneity of Cellular Senescence: Subtype‐Specific Mechanisms and the Emerging Role of Plasma Membrane Damage	33
Novel antiangiogenic therapy targeting biglycan using tumor endothelial cell‐specific liposomal siRNA delivery system	33
Efficacy and biomarker analysis of second‐line nab‐paclitaxel plus sintilimab in patients with advanced biliary tract cancer	33
Dysregulated minor intron splicing in cancer	33
Emergence of PALB2 Reversion Mutations as a Mechanism of Resistance to Niraparib in Breast Cancer:	32
Issue Information	32
Interleukin‐4 induced 1‐mediated resistance to an immune checkpoint inhibitor through suppression of CD8⁺ T cell infiltration in melanoma	32
	31
In this issue	31
ctDNA predicts clinical T1a to pathological T3a upstaging after partial nephrectomy	31
Issue Information	31
In This Issue	31
Biological effectiveness and relative biological effectiveness of ion beams for in‐vitro cell irradiation	29
Lysyl oxidase‐like 2 promotes stemness and enhances antitumor effects of gefitinib in head and neck cancer via IFIT1 and IFIT3	29
When and how should next‐generation sequencing and comprehensive genomic profiling assays be performed?	29
Promotion of squamous cell carcinoma tumorigenesis by oncogene‐mediated THG‐1/TSC22D4 phosphorylation	29
Inhibition of the bone morphogenetic protein pathway suppresses tumor growth through downregulation of epidermal growth factor receptor in MEK/ERK‐dependent colorectal cancer	29
Correction to “G protein pathway suppressor 2 suppresses gastric cancer by destabilizing epidermal growth factor receptor”	29
Concerning trends and potential issues in osteosarcoma research publication	29
Serial comprehensive genomic profiling by next‐generation sequencing for patients with metastatic colorectal cancer	29
A gain‐of‐function mutation in microRNA 142 is sufficient to cause the development of T‐cell leukemia in mice	29
Prognostic impact of the presence or absence of prior cancer in patients with cancer using cure models: A population‐based study	29
Correction	28
Multiplex plasma protein assays as a diagnostic tool for lung cancer	28
Diversity of U1 Small Nuclear RNAs and Diagnostic Methods for Their Mutations	28
Carbon ion radiotherapy with pencil beam scanning for hepatocellular carcinoma: Long‐term outcomes from a phase I trial	28
Retinol binding protein 1‐dependent activation of NF‐ κB signaling enhances the malignancy of non‐glioblastomatous diffuse gliomas	28
Rafoxanide negatively modulates STAT3 and NF‐κB activity and inflammation‐associated colon tumorigenesis	28
Carbonic Anhydrase 12 as a Novel Prognostic Biomarker and Therapeutic Target for High‐Risk Follicular Thyroid Carcinoma	28

ABCA9, an ER cholesterol transporter, inhibits breast cancer cell proliferation via SREBP‐2 signaling	28
NFATc4 Promotes Lung Adenocarcinoma Progression via the CCNB1/CDK1 Pathway and Is a Potential Prognostic Biomarker	28
Pleckstrin‐2‐promoted PPM1B degradation plays an important role in transforming growth factor‐β‐induced breast cancer cell invasion and metastasis	28
Lymphoproliferative disorder risk after methotrexate treatment for rheumatoid arthritis	27
Personalized medicine with germline pathogenic variants: Importance of population‐ and region‐wide evidence	27
Canonical and Non‐Canonical Functions of Histone H3K4 Methylation Modifiers in Cancer	27
Genotype–phenotype correlation for extracolonic aggressive phenotypes in patients with familial adenomatous polyposis	27
Distribution of Ectopic Germinal Centers in Thymic Epithelial Tumors and Their Relationship With Thymic Involution	27
Metformin inhibits the proliferation and invasion of ovarian cancer cells by suppressing tripartite motif‐containing 37‐induced tumor necrosis factor receptor‐associated factor 2 ubiquitination	26
Survival rate prediction of nasopharyngeal carcinoma patients based on MRI and gene expression using a deep neural network	26
FZD10‐targeted α‐radioimmunotherapy with ²²⁵Ac‐labeled OTSA101 achieves complete remission in a synovial sarcoma model	26
The oncogenic driving force of CD30 signaling‐induced chromosomal instability in adult T‐cell leukemia/lymphoma	26
HNRNPC suppresses tumor immune microenvironment by activating Treg cells promoting the progression of prostate cancer	25
Hepatic stellate cell‐released CXCL1 aggravates HCC malignant behaviors through the MIR4435‐2HG/miR‐506‐3p/TGFB1 axis	25
CDX2 Promoter‐Controlled Oncolytic Adenovirus Suppresses Tumor Growth and Liver Metastasis of Colorectal Cancer	25
Gut microbiome as a biomarker for predicting early recurrence of HBV‐related hepatocellular carcinoma	25
LRRC75A‐AS1 delivered by M2 macrophage exosomes promotes cervical cancer progression via enhancing SIX1 expression	25
Neoadjuvant nivolumab plus chemotherapy in resectable non‐small‐cell lung cancer in Japanese patients from CheckMate 816	25
LS‐106, a novel EGFR inhibitor targeting C797S, exhibits antitumor activities both in vitro and in vivo	25
Chronological improvement in precision oncology implementation in Japan	25
	24
Molecular subtyping of small‐cell lung cancer based on mutational signatures with different genomic features and therapeutic strategies	24
Methyltransferase like‐14 suppresses growth and metastasis of non‐small‐cell lung cancer by decreasing LINC02747	24
Effect of fasting on cancer: A narrative review of scientific evidence	24
In this issue	24
Rev1 overexpression accelerates N‐methyl‐N‐nitrosourea (MNU)‐induced thymic lymphoma by increasing mutagenesis	24
Cholesterol synthesis is essential for the growth of liver metastasis‐prone colorectal cancer cells	24
Effectiveness of human papillomavirus vaccine against cervical precancer in Japan: Multivariate analyses adjusted for sexual activity	24
Impact of Minimal Residual Disease on Early Recurrence of Liver Metastatic Colorectal Cancer	24
	24
Fibrocytes in tumor microenvironment: Identification of their fraction and novel therapeutic strategy	23
Growth pattern of de novo small clusters of colorectal cancer is regulated by Notch signaling at detachment	23
A Robust Immunohistochemistry‐Based Classification for BRAF V600E ‐Mutant Colorectal Cancer With Clinical Implications	23
CircPCBP2 promotes the stemness and chemoresistance of DLBCL via targeting miR‐33a/b to disinhibit PD‐L1	23
Clinical Application of In‐House Comprehensive Genomic Profiling for Thoracic Cancer: Insights From a Japanese Hospital	23
Oncogenic FGFR1 mutation and amplification in common cellular origin in a composite tumor with neuroblastoma and pheochromocytoma	23
Efficacy and Safety of T‐ DXd in HER2 + and Low/Zero Metastatic BCBM	23
Transferrin Receptor Promotes Endometrial Cancer Proliferation by Activating the Iron‐Dependent PI3K/AKT/mTOR Signaling Pathway	22
Intraperitoneal transfer of microRNA‐29b‐containing small extracellular vesicles can suppress peritoneal metastases of gastric cancer	22
HKDC1 upregulation promotes glycolysis and disease progression, and confers chemoresistance onto gastric cancer	22
CD44v5 domain regulates crosstalk between TNBC cells and tumor‐associated macrophages by enhancing the IL‐4R/STAT3 axis	22
Mutational spectrum of ATRX aberrations in neuroblastoma and associated patient and tumor characteristics	22
H1.0 induces paclitaxel‐resistance genes expression in ovarian cancer cells by recruiting GCN5 and androgen receptor	22
Association between adherence to Eat‐Lancet diet and incidence and mortality of lung cancer: A prospective cohort study	22
Evaluating the effect of childhood sunburn on the risk of cutaneous melanoma through Mendelian randomization	22
N6 ‐Methyladenosine‐Modified circNEK11 Promotes Hepatocellular Carcinoma Progression via the	22
Silybin suppresses ovarian cancer cell proliferation by inhibiting isocitrate dehydrogenase 1 activity	22
M2‐like tumor‐associated macrophages promote epithelial–mesenchymal transition through the transforming growth factor β/Smad/zinc finger e‐box binding homeobox pathway with increased metastatic potent	22
BBOX1‐AS1 promotes gastric cardia adenocarcinoma progression via interaction with CtBP2 to facilitate the epithelial–mesenchymal transition process	22
Body mass index and esophageal and gastric cancer: A pooled analysis of 10 population‐based cohort studies in Japan	21
RITA1 drives the growth of bladder cancer cells by recruiting TRIM25 to facilitate the proteasomal degradation of RBPJ	21
Novel specific anti‐ESM1 antibodies overcome tumor bevacizumab resistance by suppressing angiogenesis and metastasis	21
In this issue	21
Phase I trial of apatinib and paclitaxel+oxaliplatin+5‐FU/levoleucovorin for treatment‐naïve advanced gastric cancer	21
Clinical features and treatment outcomes of dedifferentiated and grade 3 chondrosarcoma: A multi‐institutional study	21
IL‐27 improves adoptive CD8⁺ T cells’ antitumor activity via enhancing cell survival and memory T cell differentiation	21
From Genomic and Epigenomic Maps to Medicines in Adult T‐Cell Leukemia/Lymphoma	21
Circulating cancer‐associated extracellular vesicles as early detection and recurrence biomarkers for pancreatic cancer	21
Efficacy of gilteritinib in comparison with alectinib for the treatment of ALK‐rearranged non‐small cell lung cancer	21
Correction to Circular RNA hsa_circ_001895 serves as a sponge of microRNA‐296‐5p to promote clear cell renal cell carcinoma progression by regulating SOX12	21
In this issue	20
	20
Dysfunction of CD8⁺ T cells around tumor cells leads to occult lymph node metastasis in NSCLC patients	20
	20
Multiple cancer type classification by small RNA expression profiles with plasma samples from multiple facilities	20
Neon ion (²⁰Ne¹⁰⁺) charged particle beams manipulate rapid tumor reoxygenation in syngeneic mouse models	20
	20
Metabolism score and machine learning models for the prediction of esophageal squamous cell carcinoma progression	20
Incidence and risk factors for venous thromboembolism, bleeding, and death in colorectal cancer (Cancer‐VTE Registry)	20
Role of catecholamine synthases in the maintenance of cancer stem‐like cells in malignant peripheral nerve sheath tumors	20
GADD45β‐MTK1 signaling axis mediates oncogenic stress‐induced activation of the p38 and JNK pathways	20
Abstracts	20
Attitudes toward cancer screening in regional Japan during the COVID‐19 pandemic: An anonymous survey	20
PD‐1 blockade treatment in melanoma: Mechanism of response and tumor‐intrinsic resistance	20
	20
Incidence of second primary cancers among survivors of childhood cancer: A population‐based study, Osaka, Japan, 1975–2015	20
In Vitro Expansion and Transduction of Primary NK Cells Using Feeder Cells Expressing Costimulatory Molecules and IL‐21	19
Durvalumab after chemoradiotherapy for locoregional recurrence of completely resected non–small‐cell lung cancer (NEJ056)	19
Immunoglobulin‐like transcript 2 blockade restores antitumor immune responses in glioblastoma	19
Carbon‐ion radiotherapy for oligometastatic liver disease: A national multicentric study by the Japan Carbon‐Ion Radiation Oncology Study Group (J‐CROS)	19

SIRT7 promotes Hippo/YAP activation and cancer cell proliferation in hepatocellular carcinoma via suppressing MST1	19
ELF1 suppresses autophagy to reduce cisplatin resistance via the miR‐152‐3p/NCAM1/ERK axis in lung cancer cells	19
PSMD14/E2F1 Axis‐Mediated CENPF Promotes the Metastasis of Triple‐Negative Breast Cancer Through Inhibiting Ferroptosis	19
Discovery‐Replication Strategy Identifies Serum Metabolite Biomarkers for Colorectal Cancer in a Chinese Cohort	19
Drug repositioning of tranilast to sensitize a cancer therapy by targeting cancer‐associated fibroblast	19
Fibrous corona is reduced in cancer cell lines that attenuate microtubule nucleation from kinetochores	19
Fat mass and obesity‐associated protein regulates arecoline‐exposed oral cancer immune response through programmed cell death‐ligand 1	19
	19
ATR Inhibition Synergizes With Alkylating PI Polyamide Targeting MYCN by Suppressing DNA Repair in MYCN‐Amplified Neuroblastoma	19
Glycoprotein NMB promotes tumor formation and malignant progression of laryngeal squamous cell carcinoma	19
Single‐Cell RNA ‐Seq Reveals the Effect of Commensal Bacteria on the Multistep Development of Esophageal Cancer	18
Connexin43 Promotes the Invasion and Metastasis of Lung Squamous Cell Carcinoma via GJIC‐Dependent Ca²⁺/ERK Signaling Activation	18
Perioperative circulating tumor DNA enables the identification of patients with poor prognosis in upper tract urothelial carcinoma	18
A single immunization with cellular vaccine confers dual protection against SARS‐CoV‐2 and cancer	18
In This Issue	18
Ligand‐Based CAR‐T Cells Targeting EGFR Exhibit Favorable Antitumor Effects Against Gynecologic Malignancies	18
Circular RNA circARHGEF28 inhibited the progression of prostate cancer via the miR‐671‐5p/LGALS3BP/NF‐κB axis	18
Mutation Analysis of TMB‐High Colorectal Cancer: Insights Into Molecular Pathways and Clinical Implications	18
The Black Hole of Immune Checkpoint Blocking Therapy for Gastric Cancer: Hyperprogressive Disease	18
Issue Information	18
Real‐World Comparison of Gene‐Matched vs. Non‐Gene‐Matched Therapy Outcomes Using Integrated Genomic and Clinical Data	18
Novel Methylation‐Based Model for Accurate Diagnosis of Upper Mediastinal Lymph Node Metastasis in Esophagogastric Junction Adenocarcinoma	18
Extensive analysis of 59 sarcoma‐related fusion genes identified pazopanib as a potential inhibitor to COL1A1‐PDGFB fusion gene	17
Mutational analysis of DNMT3A improves the prognostic stratification of patients with acute myeloid leukemia	17
Comprehensive Colorectal Cancer Stem Cell Transcriptomic Signatures That Can Predict Patient Prognostic Outcomes	17
Elotuzumab‐mediated ADCC with Th1‐like Vγ9Vδ2 T cells to disrupt myeloma–osteoclast interaction	17
Evans Blue Acts as a Selective Inhibitor of CaMKII‐α to Impede the Progression of TCL Identified by HTS	17
The LGALS9 / miR ‐491‐5p Axis Regulates CD8	17
Changes in survival of patients with non–small cell lung cancer in Japan: An interrupted time series study	17
ZNF500 abolishes breast cancer proliferation and sensitizes chemotherapy by stabilizing P53 via competing with MDM2	17
Molecular subtypes of lung adenocarcinoma present distinct immune tumor microenvironments	17
MED27 plays a tumor‐promoting role in breast cancer progression by targeting KLF4	17
Phase I trial of myeloablative conditioning with 3‐day total marrow and lymphoid irradiation for leukemia	17
A Novel Method for Prognostic Risk Classification After Carbon‐Ion Radiotherapy for Hepatocellular Carcinoma Using Data‐Mining Methods	17
Adaptive use of error‐prone DNA polymerases provides flexibility in genome replication during tumorigenesis	17
Spatial omics technologies for understanding molecular status associated with cancer progression	17
Phospholipid metabolic adaptation promotes survival of IDH2 mutant acute myeloid leukemia cells	17
Prognostic impact of cancer genomic profile testing for advanced or metastatic solid tumors in clinical practice	17
MFN2 suppresses the accumulation of lipid droplets and the progression of clear cell renal cell carcinoma	17
Second Opinion Referrals of Cancer Patients in Japan—A Nationwide Study	17
Transcriptional suppression of Dicer by HOXB‐AS3/EZH2 complex dictates sorafenib resistance and cancer stemness	16
Nationwide Real‐World Usage of Blood‐Based (Liquid) Biomarker Testing in Japan	16
CENPF as an independent prognostic and metastasis biomarker corresponding to CD4+ memory T cells in cutaneous melanoma	16
Realizing Equitable Precision Oncology via Remote Participation: Japan's First Fully Decentralized Trial ( WJOG15221M )	16
Serum untargeted metabolomics reveal metabolic alteration of non‐small cell lung cancer and refine disease detection	16
Pan‐immune‐inflammation value predicts immunotherapy response and reflects local antitumor immune response in rectal cancer	16
Metabolic stress‐induced reciprocal loop of long noncoding RNA ZFAS1 and ZEB1 promotes epithelial–mesenchymal transition and metastasis of pancreatic cancer cells	16
Ciltacabtagene autoleucel in patients with relapsed/refractory multiple myeloma: CARTITUDE‐1 (phase 2) Japanese cohort	16
Senescent CD8⁺ T cells acquire NK cell‐like innate functions to promote antitumor immunity	16
Senescence and senolysis in cancer: The latest findings	16
Characterization and clinical implications of different malignant transformation patterns in diffuse low‐grade gliomas	16
SHARPIN promotes cell proliferation of cholangiocarcinoma and inhibits ferroptosis via p53/SLC7A11/GPX4 signaling	16
Identification and validation of a poor clinical outcome subtype of primary prostate cancer with Midkine abundance	16
A combination of lymphatic drug delivery of anti‐CTLA‐4 antibody and local radiotherapy for solid‐tumor treatment	16
Single‐cell transcriptomic analysis of gingivo‐buccal oral cancer reveals two dominant cellular programs	16
A YAP / TAZ – CDC6 Axis Initiates and Maintains	16
STAT3 regulates 5‐Fu resistance in human colorectal cancer cells by promoting Mcl‐1–dependent cytoprotective autophagy	16
Tertiary lymphoid structure and neutrophil–lymphocyte ratio coordinately predict outcome of pembrolizumab	16
CircBRD7 attenuates tumor growth and metastasis in nasopharyngeal carcinoma via epigenetic activation of its host gene	15
Growth arrest‐specific transcript 5 represses endometrial cancer development by promoting antitumor function of tumor‐associated macrophages	15
Patient survey on cancer genomic medicine in Japan under the national health insurance system	15
lncDILC Downregulation in Liver Cancer‐Associated Fibroblasts Drives Pro‐Invasive Conversion via a miR ‐6071‐	15
circEZH2^E2^/E3 is a dual suppressor of miR363/miR708 to promote EZH2 expression and prostate cancer progression	15
Cancer metabolism challenges genomic instability and clonal evolution as therapeutic targets	15
CORRECTION	15
CORRECTION	15
Correction to “Long noncoding RNA SNHG3 interacts with microRNA‐502‐3p to mediate ITGA6 expression in liver hepatocellular carcinoma”	15
New insights into the genetic contribution of ALDH2 rs671 in pancreatic carcinogenesis: Evaluation by mediation analysis	15
MEN1 deficiency stabilizes PD‐L1 and promotes tumor immune evasion of lung cancer	15
Newly developed humanized anti‐CKAP4 antibody suppresses pancreatic cancer growth by inhibiting DKK1‐CKAP4 signaling	15
Role of EMT in the DNA damage response, double‐strand break repair pathway choice and its implications in cancer treatment	15
The cancer epigenome: Non‐cell autonomous player in tumor immunity	15
Novel TEAD1 Inhibitor VT103 Enhances Dabrafenib Efficacy in BRAFV600E Mutated Lung Adenocarcinoma via Survivin Downregulation	15
Correction	15
RETRACTION: MicroRNA‐16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor‐κB1/MMP9 signaling pathway	15
Noncanonical TCA cycle fosters canonical TCA cycle and mitochondrial integrity in acute myeloid leukemia	15
Correction to “Upregulation of HLA‐II Related to LAG‐3⁺CD4⁺ T Cell Infiltration is Associated With Patient Outcome in Human Glioblasto	15
Phase IIb study of pembrolizumab combined with S‐1 + oxaliplatin or S‐1 + cisplatin as first‐line chemotherapy for gastric cancer	15
Fat and proteolysis due to methionine, tryptophan, and niacin deficiency leads to alterations in gut microbiota and immune modulation in inflammatory bowel disease	15
Trends in patterns of treatment and survival of colorectal cancer patients using cancer registry data in Japan: 1995–2015	15
Alvocidib inhibits IRF4 expression via super‐enhancer suppression and adult T‐cell leukemia/lymphoma cell growth	15
	15
p53 Arg72Pro polymorphism, adiposity status, and cancer risk: Two case‐cohorts within a Japanese prospective study	15
Metronomic chemotherapy for indolent T‐cell lymphoproliferative disorder of the gastrointestinal tract	15
Novel positron emission tomography imaging targeting cell surface glycans for pancreatic cancer: ¹⁸F‐labeled rBC2LCN lectin	15
AXL‐Mediated Drug Resistance in ALK‐Rearranged NSCLC Enhanced by GAS6 From Macrophages and MMP11 Positive Fibroblasts	15
	14
Loss of SMARCA4 induces sarcomatogenesis through epithelial–mesenchymal transition in ovarian carcinosarcoma	14
Correction to: HDAC5, Negatively regulated by miR‐ 148a‐ 3p, promotes colon cancer cell migration	14
N6‐methyladenosine‐modified HOTAIRM1 promotes vasculogenic mimicry formation in glioma	14
Targeting Cancer With Bifunctional Peptides: Mechanism of Cell Entry and Inciting Cell Death	14
Targeting RNA Polymerase I in Ewing Sarcoma Treatment	14
Durvalumab Post Concurrent Chemoradiotherapy in Japanese Patients With Limited‐Stage Small‐Cell Lung Cancer in the Phase 3 ADRIATIC Trial	14
Characterization of starvation response‐related genes for predicting prognosis in breast cancer	14
	14